Funded Projects
The American Craft Exposition (ACE) is committed to supporting research and clinical programs at NorthShore University HealthSystem (NorthShore). In 2020 and 2021, ACE will support an initiative to protect and preserve the health of pregnant and postpartum women at NorthShore. To make a donation to support these efforts, please click here.
In 2018 and 2019, ACE supported the creation of a Psychiatric Urgent Care Program and the implementation of a Collaborative Care Model for providing mental health services to families. These programs aim to vastly minimize wait times for patients who are in need of urgent psychiatric care, as well as assist primary care physicians with the management of patients with low to medium risk factors. The Auxiliary of NorthShore University HealthSystem is proud to announce that net proceeds raised over two years for these initiatives total over $1.13 million.
Past research projects funded by ACE include:
2018-2019
Mark Drexler, MD and Frederick Miller, MD, PhD
Development and implementation of a Psychiatric Urgent Care Program and Collaborative Care Model.
2017
Karen Kaul, MD
Pharmacogenomics research analyzing how patients react to medications based on genetic variants.
Jason Koh, MD
Orthopaedic regenerative medicine research at the NorthShore Orthopaedic Institute.
2016
Karen Kaul, MD
Pharmacogenomics research analyzing how patients react to medications based on genetic variants.
2011-2015
Gustavo Rodriguez, MD
Development of a Progestin-Based Pharmacologic Approach for the Effective Prevention of Ovarian Cancer
2010
Clinical Research Coordinator for Breast and Ovarian Cancer Research
2009
Breast Cancer Research Fellowship
2008
Manjari Dimri, MD
Identification of Oncologic Lesions Involved in Invasive and Refractory Breast Cancer
San Ming Wang, MD
Identifying New Breast Cancer Susceptibility Genes
2007
Jean Hurteau, MD
Progestin and Eicosanoid Combination for Chemoprevention of Ovarian Cancer
Gurumurthy, PhD
hEcd, a Novelmarker for Breast Cancer
Raja Srikumar, PhD
Combinatorial Targeting of ErbB2-HSPop Towards Treatment of ErbB2-related Breast Cancer Tumors
2006
Sofia F. Garcia, Ph.D.
Real-time Symptom Monitoring via Computer Telephony in Patients with Advanced Breast Cancer
Xijin Ge, Ph.D.
Bioinformatics Study on BRCA1 Transcriptional Regulation Mechanisms
Gustavo Rodriguez, MD
Development of a Progestin-Based Chemopreventive Agent for Epithelial Ovarian Cancer
2005
Javier Menendez, MD
Effects of Dietary Fatty Acids in Her-2/neu (erbB-2) Oncogene-Induced Breast Tumorigenesis and Trastuzumab (Herceptin™) Efficacy
David J. Winchester, MD
DNA Microarray Analysis of Multicentric Breast Cancers
2004
Ruth Lupu, MD
Characterization of Heregulin-Induced Activation of HER-2: As A New Molecular target in Breast Cancer
Ruth Lupu, MD
A Possible Prognostic and Therapeutic Value of Cyr61/αvβ3 Integrin
2003
Javier Menendez, MD
Pharmacological Inhibition of Fatty Acid Synthase:A New Therapeutic Approach in Her-2/neu-Overexpressing Breast Cancer
Prem K. Seth, Ph.D.
Gene Therapy for Breast Cancer: Targeting Mutant p53 and TGFβ with Replicating Adenoviruses
2002
Joseph Bass, MD, Ph.D.
Regulation of Receptor Kinase Protooncogene Activity in Breast Cancer Cells
Cheikh Menaa, Ph.D.
Cellular and Molecular Mechanism of Osteoclast Formation and Bone Metastasis Induced by Breast Cancer
David J. Winchester, MD
Endoscopic, Cytologic, and Molecular Analysis of Nipple Aspirates in Women
Susan E. Yount, Ph.D.
Quality of Breast Cancer Care
2001
Stuart Lind, MD
Effects of Coformycin and Adenosine Upon Human Breast Cancer Cells
Douglas Merkel, MD
erbB-2: Clonality and Progression in Recurrence and Metastases
XiaoHe Yang, MD
Breast Cancer Selective and DNA Damage Inducible Caspase 3 Mediated Gene Therapy
A Model of “Tissue Specific and Synchronized Double Hit” Cancer Therapy